Diabetes Care, Vol 17, Issue 7 633-639, Copyright © 1994 by American Diabetes Association

ARTICLES

Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients

DC Raev
Department of Internal Medicine, Medical Institute, Stara Zagora, Bulgaria.

OBJECTIVE--To determine whether diastolic dysfunction preceded systolic dysfunction in the evolution of diabetic cardiopathy. RESEARCH DESIGN AND METHODS--A total of 157 young (mean age 26.6 years) cardiac asymptomatic type I diabetic patients and 54 age- and sex-matched healthy (nondiabetic) subjects were studied. The severity of diabetic complications (retinopathy, nephropathy, and cardiac autonomic neuropathy) was evaluated by the diabetic complication index (DCI), a sum of individual scores for each complication. Left ventricular (LV) function was studied by M-mode echocardiography. Impaired systolic and diastolic functions were presumed if at least two echocardiographic variables for systolic function (fractional shortening [FS], mean velocity of circumference fiber shortening, and stroke index) and for diastolic function (slope of anterior mitral leaflet in early diastole, isovolumic relaxation time [IRT], and left atrium emptying index) were out of the control range (mean +/- 2 SD). RESULTS--Diastolic dysfunction was twice as common as systolic dysfunction (27% and 12%, respectively, P < 0.001). Of diabetic patients with systolic dysfunction, 83% had impaired diastolic function, whereas only 30% of diabetic patients with diastolic dysfunction had systolic damage (P < 0.001). On the other hand, only 3 of 157 diabetic patients (1.9%) had systolic dysfunction with preserved diastolic function (P > 0.05). Diastolic dysfunction, represented by the interval from minimal LV dimension to mitral valve opening, was seen in diabetic patients approximately 8 years after onset of diabetes and systolic dysfunction represented by FS after approximately 18 years. Diastolic dysfunction, represented by IRT, was found in the presence of mild complications (DCI = 2), and systolic dysfunction, represented by FS, was found in the presence of more severe complications (DCI = 4). CONCLUSIONS--Our findings indicate that myocardial damage in patients with diabetes affects diastolic function before systolic function. The intentional assessment of diastolic function is advisable for early detection of LV dysfunction before clinical symptoms appear, with follow-up to detect further deterioration of cardiac status.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. D. Karamitsos, A. Tsapas, and J. R. Arnold Diabetic cardiomyopathy: a controversial entity Eur. Heart J., February 2, 2008; 29(4): 564 - 564. [Full Text] [PDF]

				P. Symeonides, S. Koulouris, E. Vratsista, K. Triantafyllou, G. Ioannidis, N. Thalassinos, and D. Katritsis Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: A comparative study Eur J Echocardiogr, December 1, 2007; 8(6): 480 - 486. [Abstract] [Full Text] [PDF]

				E. Konduracka, A. Gackowski, P. Rostoff, D. Galicka-Latala, W. Frasik, and W. Piwowarska Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy Eur. Heart J., October 2, 2007; 28(20): 2465 - 2471. [Abstract] [Full Text] [PDF]

				P. Yue, T. Arai, M. Terashima, A. Y. Sheikh, F. Cao, D. Charo, G. Hoyt, R. C. Robbins, E. A. Ashley, J. Wu, et al. Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2106 - H2118. [Abstract] [Full Text] [PDF]

				C. Avgeropoulou, A. Illmann, P.-M. Schumm-Draeger, J. Kallikazaros, and H. Von Bibra Assessment of arterio-ventricular coupling by tissue Doppler and wave intensity in type 2 diabetes The British Journal of Diabetes & Vascular Disease, November 1, 2006; 6(6): 271 - 278. [Abstract] [PDF]

				R. Valle, E. Bagolin, C. Canali, P. Giovinazzo, S. Barro, N. Aspromonte, E. Carbonieri, and L. Milani The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients Eur J Echocardiogr, January 1, 2006; 7(1): 40 - 44. [Abstract] [Full Text] [PDF]

				H. S. Lim, R. J. MacFadyen, and G. Y. H. Lip Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart Arch Intern Med, September 13, 2004; 164(16): 1737 - 1748. [Abstract] [Full Text] [PDF]

				Z. Y. Fang, J. B. Prins, and T. H. Marwick Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications Endocr. Rev., August 1, 2004; 25(4): 543 - 567. [Abstract] [Full Text] [PDF]

				B. E. Suys, N. Katier, R. P.A. Rooman, D. Matthys, L. Op De Beeck, M. V.L. Du Caju, and D. De Wolf Female Children and Adolescents With Type 1 Diabetes Have More Pronounced Early Echocardiographic Signs of Diabetic Cardiomyopathy Diabetes Care, August 1, 2004; 27(8): 1947 - 1953. [Abstract] [Full Text] [PDF]

				B. F. Johnson, R. W. Nesto, M. A. Pfeifer, W. R. Slater, A. I. Vinik, D. A. Chyun, G. Law, F. J.Th. Wackers, and L. H. Young Cardiac Abnormalities in Diabetic Patients With Neuropathy: Effects of aldose reductase inhibitor administration Diabetes Care, February 1, 2004; 27(2): 448 - 454. [Abstract] [Full Text] [PDF]

				B.-L. Johansson, J. Sundell, K. Ekberg, C. Jonsson, M. Seppanen, O. Raitakari, M. Luotolahti, P. Nuutila, J. Wahren, and J. Knuuti C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E14 - E19. [Abstract] [Full Text]

				T. E. Delea, J. S. Edelsberg, M. Hagiwara, G. Oster, and L. S. Phillips Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes: A retrospective cohort study Diabetes Care, November 1, 2003; 26(11): 2983 - 2989. [Abstract] [Full Text] [PDF]

				A. G. Bertoni, A. Tsai, E. K. Kasper, and F. L. Brancati Diabetes and Idiopathic Cardiomyopathy: A nationwide case-control study Diabetes Care, October 1, 2003; 26(10): 2791 - 2795. [Abstract] [Full Text] [PDF]

				T. P. Didangelos, G. A. Arsos, D. T. Karamitsos, V. G. Athyros, and N. D. Karatzas Left Ventricular Systolic and Diastolic Function in Normotensive Type 1 Diabetic Patients With or Without Autonomic Neuropathy: A radionuclide ventriculography study Diabetes Care, July 1, 2003; 26(7): 1955 - 1960. [Abstract] [Full Text] [PDF]

				K. J. Stewart Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension: Plausible Mechanisms for Improving Cardiovascular Health JAMA, October 2, 2002; 288(13): 1622 - 1631. [Abstract] [Full Text] [PDF]

				P. Poirier, P. Bogaty, C. Garneau, L. Marois, and J.-G. Dumesnil Diastolic Dysfunction in Normotensive Men with Well-Controlled Type 2 Diabetes: Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy Diabetes Care, January 1, 2001; 24(1): 5 - 10. [Abstract] [Full Text]